Background and Aims
Gastroesophageal reflux disease (GERD) encompasses an array of disorders unified by the reflux of gastric contents. Owing to the multitude of potential disease manifestations, both esophageal and extra-esophageal, no single biomarker can capture the disease spectrum, making it more plausible that there be a set of GERD biomarkers, each quantifying specific aspects of GERD-related pathology. This review aimed to comprehensively search the literature on biomarkers of GERD, specifically in relation to endoscopically negative esophageal disease and excluding conventional pH-impedance monitoring.
Methods
We searched PubMed and Embase databases from January 1st, 1996 to June 10th, 2015 for biomarkers of GERD and abstracts from recent international gastroenterology meetings.
Results
Of 1937 citations retrieved, 72 were included. Histopathologic biomarkers, baseline impedance, and serologic assays are some of the candidate biomarkers reviewed. The most unifying concept was of manifestations of impaired esophageal mucosal integrity, evident by increased ionic and molecular permeability, and/or destruction of tight junctions.
Conclusions
Impaired mucosal integrity quantified by baseline mucosal impedance, proteolytic fragments of junctional proteins, or histopathological features, has emerged as a promising GERD biomarker.